{
    "eid": "2-s2.0-85102793406",
    "title": "Multimodality treatment in immunocompromised patients with severe COVID-19: the role of IL-6 inhibitor, intravenous immunoglobulin, and haemoperfusion",
    "cover-date": "2021-04-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pulmonary and Respiratory Medicine",
            "@code": "2740",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "COVD-19",
        "haemoperfusion",
        "IVIG",
        "SARS-CoV-2",
        "tocilizumab"
    ],
    "authors": [
        "Nophol Leelayuwatanakul",
        "Napplika Kongpolprom",
        "Thitiwat Sriprasart",
        "Vorakamol Phoophiboon",
        "Vorawut Thanthitaweewat",
        "Sarita Thawanaphong",
        "Worawan Sirichana",
        "Naricha Chirakalwasan",
        "Kamon Kawkitinarong",
        "Chanchai Sittipunt",
        "Opass Putcharoen",
        "Leilani Paitoonpong",
        "Gompol Suwanpimolkul",
        "Watsamon Jantarabenjakul",
        "Nattachai Srisawat",
        "Monvasi Pachinburavan"
    ],
    "citedby-count": 2,
    "ref-count": 41,
    "ref-list": [
        "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study",
        "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China",
        "COVID-19: consider cytokine storm syndromes and immunosuppression",
        "The cytokine release syndrome (CRS) of severe COVID-19 and interleukin-6 receptor (IL-6R) antagonist tocilizumab may be the key to reduce the mortality",
        "Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology",
        "Multiple myeloma and COVID-19",
        "Dysregulation of immune response in patients with COVID-19 in Wuhan, China",
        "Tocilizumab and COVID-19",
        "Effective treatment of severe COVID-19 patients with tocilizumab",
        "Tocilizumab for the treatment of severe coronavirus disease 2019",
        "Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in Brescia, Italy",
        "Tocilizumab treatment in COVID-19: a single center experience",
        "Tocilizumab for treatment of severe COVID-19 patients: preliminary results from SMAtteo COvid19 REgistry (SMACORE)",
        "Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study",
        "Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia",
        "Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients",
        "COVACTA trial raises questions about tocilizumab's benefit in COVID-19",
        "Efficacy of tocilizumab in patients hospitalized with Covid-19",
        "First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab",
        "Case series of six kidney transplanted patients with COVID-19 pneumonia treated with tocilizumab",
        "Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin",
        "Bench-to-bedside review: immunoglobulin therapy for sepsis \u2013 biological plausibility from a critical care perspective",
        "Current proposed mechanisms of action of intravenous immunoglobulins in inflammatory neuropathies",
        "Effect of clinical and virological parameters on the level of neutralizing antibody against pandemic influenza A virus H1N1 2009",
        "Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial",
        "Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients",
        "Clinical features and outcomes of severe acute respiratory syndrome and predictive factors for acute respiratory distress syndrome",
        "Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo",
        "Critically ill patients with the Middle East respiratory syndrome: a multicenter retrospective cohort study",
        "Currently available intravenous immunoglobulin contains antibodies reacting against severe acute respiratory syndrome coronavirus 2 antigens",
        "Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection",
        "Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study",
        "Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19",
        "High-dose intravenous immunoglobulin as a therapeutic option for deteriorating patients with coronavirus disease 2019",
        "Recovery of severely ill COVID-19 patients by intravenous immunoglobulin (IVIG) treatment: a case series",
        "Clinical efficacy of intravenous immunoglobulin therapy in critical ill patients with COVID-19: a multicenter retrospective cohort study",
        "Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study",
        "Endotoxemia and circulating bacteriome in severe COVID-19 patients",
        "Polymyxin B hemoperfusion in COVID-19 patients with endotoxic shock: case series from EUPHAS II registry",
        "Polymyxin B haemoperfusion treatment for respiratory failure and hyperferritinaemia due to COVID-19"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Thai Red Cross Emerging Infectious Diseases",
        "King Chulalongkorn Memorial Hospital"
    ]
}